Cetoacidosis diabética euglicémica asociada a inhibidor de cotransportador de sodio glucosa Tipo 2 en paciente con diabetes Mellitus Tipo 1 / Diabetic ketoacidosis with mild hyperglycemia associated with the use of canagliflozin. report of one case with type 1 diabetes
Rev. méd. Chile
; 145(3): 393-396, Mar. 2017.
Article
de Es
| LILACS
| ID: biblio-845553
Bibliothèque responsable:
CL1.1
ABSTRACT
Diabetic ketoacidosis with mild hyperglycemia is a major complication of sodium-glucose cotransporter 2 inhibitors. Although its use is not approved for patients with type 1 diabetes mellitus, the drug is often prescribed with the hope of optimizing metabolic control. We report a 20 years old female with hypothyroidism and type 1 diabetes consulting for vomiting and abdominal pain. The patient had used canagliflozin during the two previous months. Laboratory showed a blood glucose of 200 mg/dl, a severe metabolic acidosis (pH 7.1) and ketonemia. The patient was successfully treated in the intensive care unit.
Mots clés
Texte intégral:
1
Indice:
LILACS
Sujet Principal:
Acidocétose diabétique
/
Canagliflozine
/
Hyperglycémie
/
Hypoglycémiants
Type d'étude:
Diagnostic_studies
/
Risk_factors_studies
Limites du sujet:
Adult
/
Female
/
Humans
langue:
Es
Texte intégral:
Rev. méd. Chile
Thème du journal:
MEDICINA
Année:
2017
Type:
Article